Dexcom’s Stelo glucose biosensor is promoted as a continuous monitor that helps track glucose in the body. What separates it from other continuous glucose monitoring (CGM) systems — special ...
Stelo, which is indicated for people who don’t take insulin, had about 140,000 users at the end of the year. Dexcom launched the device in August 2024, priced at $89 for a monthly subscription ...